Association between the 110-kDa C-terminal agrin fragment and skeletal muscle decline among community-dwelling older women

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Background: C-terminal agrin fragment (CAF) is a biomarker for neuromuscular junction degradation. This study aimed to investigate whether 110-kDa CAF (CAF110) was associated with the presence and incidence of low muscle mass and strength. Methods: This cross-sectional retrospective cohort study comprised women aged ≥65 years. We measured muscle mass using a dual-energy X-ray absorptiometry scanner, hand-grip strength, and blood sampling between 2011 and 2012. A follow-up study with the same measurements was conducted between 2015 and 2017. Low muscle mass and strength were defined as an appendicular skeletal muscle mass index <5.4 kg/m2 and hand-grip strength <18 kg, respectively. The CAF110 level was measured using enzyme-linked immunosorbent assay kits. Results: In total, 515 women (74.3 ± 6.3 years) were included in this cross-sectional analysis. Of these, 101 (19.6%) and 128 (24.9%) women presented with low muscle mass and strength, respectively. For low muscle mass, the odds ratios (ORs) of the middle and highest CAF110 tertile groups, compared with the lowest group, were 1.93 (95% confidence interval: 1.09–3.43; P = 0.024) and 2.15 (1.22–3.80; P = 0.008), respectively. After adjusting for age, the ORs remained significant: 1.98 (1.11–3.52; P = 0.020) and 2.27 (1.28–4.03; P = 0.005), respectively. Low muscle strength ORs of all the CAF110 tertile groups were not significant. In the longitudinal analysis, 292 and 289 women were assessed for incidents of low muscle mass and strength, respectively. Of those, 34 (11.6%) and 20 (6.9%) women exhibited low muscle mass and strength, respectively. For incident low muscle mass, the crude OR of the CAF110 ≥ the median value group was marginally higher than that of the CAF110 < median value group (median [interquartile range]: 1.98 [0.94–4.17] (P = 0.072). After adjusting for age and baseline muscle mass, the OR was 2.22 [0.97–5.06] (P = 0.058). All low muscle strength ORs of the median categories of CAF110 were not significant. Conclusions: CAF110 was not associated with low muscle strength. However, CAF110 may be a potential marker for the incidence of low muscle mass.

References Powered by Scopus

Sarcopenia: Revised European consensus on definition and diagnosis

8280Citations
N/AReaders
Get full text

Revised Equations for Estimated GFR From Serum Creatinine in Japan

5420Citations
N/AReaders
Get full text

Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment

3875Citations
N/AReaders
Get full text

Cited by Powered by Scopus

C-Terminal Agrin Fragment as a Biomarker for Sarcopenia: A Systematic Review and Meta-Analysis

1Citations
N/AReaders
Get full text

Gut microbiota and blood biomarkers in IBD-Related arthritis: insights from mendelian randomization

0Citations
N/AReaders
Get full text

Blood biomarkers of muscle atrophy: A diagnostic opportunity

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kamiya, K., Tachiki, T., Sato, Y., Kouda, K., Kajita, E., Tamaki, J., … Iki, M. (2023). Association between the 110-kDa C-terminal agrin fragment and skeletal muscle decline among community-dwelling older women. Journal of Cachexia, Sarcopenia and Muscle, 14(5), 2253–2263. https://doi.org/10.1002/jcsm.13309

Readers over time

‘23‘24‘2501234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 1

50%

Researcher 1

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

100%

Save time finding and organizing research with Mendeley

Sign up for free
0